Reviva Pharmaceuticals Holdings, Inc. (RVPH) Tops Q2 EPS by 1c

Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) reported Q2 EPS of ($0.12), $0.01 better than the analyst estimate of ($0.13).

For earnings history and earnings-related data on Reviva Pharmaceuticals Holdings, Inc. (RVPH) click here.

You May Also Be Interested In

• John Wiley & Sons, Inc. (WLYB) Misses Q1 EPS by 2c ; Offers Guidance
• Campbell Soup (CPB) Reports In-Line Q4 EPS, Misses on Revenue; Offers FY27 EPS Guidance
• Brady Corp. (BRC) Tops Q4 EPS by 1c ; Offers Guidance